The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Monoclonal Antibody Humanization Services Market Research Report 2024
Synopsis
Monoclonal antibody humanization services refer to specialized laboratory services that focus on modifying mouse antibodies to make them more suitable for human use, reducing the risk of immune rejection and enhancing their efficacy in therapeutic applications. This process involves several steps, including the selection of appropriate human framework genes, grafting of mouse complementarity-determining regions (CDRs) into human framework proteins, and optimization of the resulting humanized antibodies for specificity and affinity. Monoclonal antibody humanization services are essential for the development of therapeutic antibodies that can effectively target disease-related antigens without eliciting an immune response from the host.
The global Monoclonal Antibody Humanization Services market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The industry trend for monoclonal antibody humanization services is experiencing significant growth due to the increasing demand for effective and safe antibody-based therapeutics. The advancements in biotechnology and computational biology have accelerated the discovery and development of antibodies, leading to the development of more targeted and effective therapeutic strategies. Additionally, the trend towards personalized and precision medicine has fueled the need for humanized antibodies that can effectively target individual patients' unique disease characteristics. Furthermore, the growing use of antibody-based drugs in oncology and other diseases is driving the need for more advanced humanization capabilities, thus contributing to the growth of this industry trend. The future of monoclonal antibody humanization services looks promising, as they continue to play a vital role in the development of novel and effective antibody-based therapeutics.
This report aims to provide a comprehensive presentation of the global market for Monoclonal Antibody Humanization Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Monoclonal Antibody Humanization Services.
Report Scope
The Monoclonal Antibody Humanization Services market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Monoclonal Antibody Humanization Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Monoclonal Antibody Humanization Services companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Absolute Antibody
Sino Biological,
Oak BioSciences
ProteoGenix
Abwiz Bio
Creative Biolabs
ProMab
Leadgene Biomedical
Syd Labs
Curia
Beijing Abace Biotechnology
Detaibio
Baiying Biological Technology
Zoonbio Biotechnology
Segment by Type
Modification Antibody
Chimeric Antibody
Fully Humanized Antibody
Segment by Application
Biotechnology
Medical
University
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Monoclonal Antibody Humanization Services companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Monoclonal antibody humanization services refer to specialized laboratory services that focus on modifying mouse antibodies to make them more suitable for human use, reducing the risk of immune rejection and enhancing their efficacy in therapeutic applications. This process involves several steps, including the selection of appropriate human framework genes, grafting of mouse complementarity-determining regions (CDRs) into human framework proteins, and optimization of the resulting humanized antibodies for specificity and affinity. Monoclonal antibody humanization services are essential for the development of therapeutic antibodies that can effectively target disease-related antigens without eliciting an immune response from the host.
The global Monoclonal Antibody Humanization Services market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The industry trend for monoclonal antibody humanization services is experiencing significant growth due to the increasing demand for effective and safe antibody-based therapeutics. The advancements in biotechnology and computational biology have accelerated the discovery and development of antibodies, leading to the development of more targeted and effective therapeutic strategies. Additionally, the trend towards personalized and precision medicine has fueled the need for humanized antibodies that can effectively target individual patients' unique disease characteristics. Furthermore, the growing use of antibody-based drugs in oncology and other diseases is driving the need for more advanced humanization capabilities, thus contributing to the growth of this industry trend. The future of monoclonal antibody humanization services looks promising, as they continue to play a vital role in the development of novel and effective antibody-based therapeutics.
This report aims to provide a comprehensive presentation of the global market for Monoclonal Antibody Humanization Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Monoclonal Antibody Humanization Services.
Report Scope
The Monoclonal Antibody Humanization Services market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Monoclonal Antibody Humanization Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Monoclonal Antibody Humanization Services companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Absolute Antibody
Sino Biological,
Oak BioSciences
ProteoGenix
Abwiz Bio
Creative Biolabs
ProMab
Leadgene Biomedical
Syd Labs
Curia
Beijing Abace Biotechnology
Detaibio
Baiying Biological Technology
Zoonbio Biotechnology
Segment by Type
Modification Antibody
Chimeric Antibody
Fully Humanized Antibody
Segment by Application
Biotechnology
Medical
University
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Monoclonal Antibody Humanization Services companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Monoclonal Antibody Humanization Services Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Modification Antibody
1.2.3 Chimeric Antibody
1.2.4 Fully Humanized Antibody
1.3 Market by Application
1.3.1 Global Monoclonal Antibody Humanization Services Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Biotechnology
1.3.3 Medical
1.3.4 University
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Monoclonal Antibody Humanization Services Market Perspective (2019-2030)
2.2 Monoclonal Antibody Humanization Services Growth Trends by Region
2.2.1 Global Monoclonal Antibody Humanization Services Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Monoclonal Antibody Humanization Services Historic Market Size by Region (2019-2024)
2.2.3 Monoclonal Antibody Humanization Services Forecasted Market Size by Region (2025-2030)
2.3 Monoclonal Antibody Humanization Services Market Dynamics
2.3.1 Monoclonal Antibody Humanization Services Industry Trends
2.3.2 Monoclonal Antibody Humanization Services Market Drivers
2.3.3 Monoclonal Antibody Humanization Services Market Challenges
2.3.4 Monoclonal Antibody Humanization Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Monoclonal Antibody Humanization Services Players by Revenue
3.1.1 Global Top Monoclonal Antibody Humanization Services Players by Revenue (2019-2024)
3.1.2 Global Monoclonal Antibody Humanization Services Revenue Market Share by Players (2019-2024)
3.2 Global Monoclonal Antibody Humanization Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Monoclonal Antibody Humanization Services Revenue
3.4 Global Monoclonal Antibody Humanization Services Market Concentration Ratio
3.4.1 Global Monoclonal Antibody Humanization Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Monoclonal Antibody Humanization Services Revenue in 2023
3.5 Monoclonal Antibody Humanization Services Key Players Head office and Area Served
3.6 Key Players Monoclonal Antibody Humanization Services Product Solution and Service
3.7 Date of Enter into Monoclonal Antibody Humanization Services Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Monoclonal Antibody Humanization Services Breakdown Data by Type
4.1 Global Monoclonal Antibody Humanization Services Historic Market Size by Type (2019-2024)
4.2 Global Monoclonal Antibody Humanization Services Forecasted Market Size by Type (2025-2030)
5 Monoclonal Antibody Humanization Services Breakdown Data by Application
5.1 Global Monoclonal Antibody Humanization Services Historic Market Size by Application (2019-2024)
5.2 Global Monoclonal Antibody Humanization Services Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Monoclonal Antibody Humanization Services Market Size (2019-2030)
6.2 North America Monoclonal Antibody Humanization Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Monoclonal Antibody Humanization Services Market Size by Country (2019-2024)
6.4 North America Monoclonal Antibody Humanization Services Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Monoclonal Antibody Humanization Services Market Size (2019-2030)
7.2 Europe Monoclonal Antibody Humanization Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Monoclonal Antibody Humanization Services Market Size by Country (2019-2024)
7.4 Europe Monoclonal Antibody Humanization Services Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Monoclonal Antibody Humanization Services Market Size (2019-2030)
8.2 Asia-Pacific Monoclonal Antibody Humanization Services Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Monoclonal Antibody Humanization Services Market Size by Region (2019-2024)
8.4 Asia-Pacific Monoclonal Antibody Humanization Services Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Monoclonal Antibody Humanization Services Market Size (2019-2030)
9.2 Latin America Monoclonal Antibody Humanization Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Monoclonal Antibody Humanization Services Market Size by Country (2019-2024)
9.4 Latin America Monoclonal Antibody Humanization Services Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Monoclonal Antibody Humanization Services Market Size (2019-2030)
10.2 Middle East & Africa Monoclonal Antibody Humanization Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Monoclonal Antibody Humanization Services Market Size by Country (2019-2024)
10.4 Middle East & Africa Monoclonal Antibody Humanization Services Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Absolute Antibody
11.1.1 Absolute Antibody Company Detail
11.1.2 Absolute Antibody Business Overview
11.1.3 Absolute Antibody Monoclonal Antibody Humanization Services Introduction
11.1.4 Absolute Antibody Revenue in Monoclonal Antibody Humanization Services Business (2019-2024)
11.1.5 Absolute Antibody Recent Development
11.2 Sino Biological,
11.2.1 Sino Biological, Company Detail
11.2.2 Sino Biological, Business Overview
11.2.3 Sino Biological, Monoclonal Antibody Humanization Services Introduction
11.2.4 Sino Biological, Revenue in Monoclonal Antibody Humanization Services Business (2019-2024)
11.2.5 Sino Biological, Recent Development
11.3 Oak BioSciences
11.3.1 Oak BioSciences Company Detail
11.3.2 Oak BioSciences Business Overview
11.3.3 Oak BioSciences Monoclonal Antibody Humanization Services Introduction
11.3.4 Oak BioSciences Revenue in Monoclonal Antibody Humanization Services Business (2019-2024)
11.3.5 Oak BioSciences Recent Development
11.4 ProteoGenix
11.4.1 ProteoGenix Company Detail
11.4.2 ProteoGenix Business Overview
11.4.3 ProteoGenix Monoclonal Antibody Humanization Services Introduction
11.4.4 ProteoGenix Revenue in Monoclonal Antibody Humanization Services Business (2019-2024)
11.4.5 ProteoGenix Recent Development
11.5 Abwiz Bio
11.5.1 Abwiz Bio Company Detail
11.5.2 Abwiz Bio Business Overview
11.5.3 Abwiz Bio Monoclonal Antibody Humanization Services Introduction
11.5.4 Abwiz Bio Revenue in Monoclonal Antibody Humanization Services Business (2019-2024)
11.5.5 Abwiz Bio Recent Development
11.6 Creative Biolabs
11.6.1 Creative Biolabs Company Detail
11.6.2 Creative Biolabs Business Overview
11.6.3 Creative Biolabs Monoclonal Antibody Humanization Services Introduction
11.6.4 Creative Biolabs Revenue in Monoclonal Antibody Humanization Services Business (2019-2024)
11.6.5 Creative Biolabs Recent Development
11.7 ProMab
11.7.1 ProMab Company Detail
11.7.2 ProMab Business Overview
11.7.3 ProMab Monoclonal Antibody Humanization Services Introduction
11.7.4 ProMab Revenue in Monoclonal Antibody Humanization Services Business (2019-2024)
11.7.5 ProMab Recent Development
11.8 Leadgene Biomedical
11.8.1 Leadgene Biomedical Company Detail
11.8.2 Leadgene Biomedical Business Overview
11.8.3 Leadgene Biomedical Monoclonal Antibody Humanization Services Introduction
11.8.4 Leadgene Biomedical Revenue in Monoclonal Antibody Humanization Services Business (2019-2024)
11.8.5 Leadgene Biomedical Recent Development
11.9 Syd Labs
11.9.1 Syd Labs Company Detail
11.9.2 Syd Labs Business Overview
11.9.3 Syd Labs Monoclonal Antibody Humanization Services Introduction
11.9.4 Syd Labs Revenue in Monoclonal Antibody Humanization Services Business (2019-2024)
11.9.5 Syd Labs Recent Development
11.10 Curia
11.10.1 Curia Company Detail
11.10.2 Curia Business Overview
11.10.3 Curia Monoclonal Antibody Humanization Services Introduction
11.10.4 Curia Revenue in Monoclonal Antibody Humanization Services Business (2019-2024)
11.10.5 Curia Recent Development
11.11 Beijing Abace Biotechnology
11.11.1 Beijing Abace Biotechnology Company Detail
11.11.2 Beijing Abace Biotechnology Business Overview
11.11.3 Beijing Abace Biotechnology Monoclonal Antibody Humanization Services Introduction
11.11.4 Beijing Abace Biotechnology Revenue in Monoclonal Antibody Humanization Services Business (2019-2024)
11.11.5 Beijing Abace Biotechnology Recent Development
11.12 Detaibio
11.12.1 Detaibio Company Detail
11.12.2 Detaibio Business Overview
11.12.3 Detaibio Monoclonal Antibody Humanization Services Introduction
11.12.4 Detaibio Revenue in Monoclonal Antibody Humanization Services Business (2019-2024)
11.12.5 Detaibio Recent Development
11.13 Baiying Biological Technology
11.13.1 Baiying Biological Technology Company Detail
11.13.2 Baiying Biological Technology Business Overview
11.13.3 Baiying Biological Technology Monoclonal Antibody Humanization Services Introduction
11.13.4 Baiying Biological Technology Revenue in Monoclonal Antibody Humanization Services Business (2019-2024)
11.13.5 Baiying Biological Technology Recent Development
11.14 Zoonbio Biotechnology
11.14.1 Zoonbio Biotechnology Company Detail
11.14.2 Zoonbio Biotechnology Business Overview
11.14.3 Zoonbio Biotechnology Monoclonal Antibody Humanization Services Introduction
11.14.4 Zoonbio Biotechnology Revenue in Monoclonal Antibody Humanization Services Business (2019-2024)
11.14.5 Zoonbio Biotechnology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
